Biotech venture capital is on the precipice of a generational shift. At least, that’s according to the crowd of younger firm ...
A progressive approach to drug approval would balance the reality of drug safety and efficacy research with the desire to get ...
The federal government’s work on long Covid has been fitful and disappointing. Now even those efforts seem to be nearing an ...
Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is ...
A child in Texas has died from measles, officials said Wednesday, the first known death in the current large outbreak in West ...
Universities accept less than their actual overhead costs from private sources because they're a minor piece of research budgets.
Enrollment in private Medicare Advantage plans grew just 3.1%, below projections from Wall Street or the government.
The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in ...
GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading into a federal court case over abortion access ...
The bill would allow Medicare to begin negotiating with pharmaceutical companies over prices for small molecule medicines 13 ...
The USDA's new plan tackles H5N1 bird flu as an issue of economic concern, and leaves questions about how to manage the ...
The web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results